Clinical Trials Browser

Phase 2 × Uterine Cervical Neoplasms × Semaxinib × Clear all

NCT00026260 2013-06-24

SU5416 in Treating Patients With Persistent or Recurrent Cervical Cancer

Phase 2 Completed

Uterine Cervical Neoplasms